These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6131801)

  • 1. The effect of haloperidol and 6-hydroxydopamine on oral drug taking behavior in rats.
    Fuchs V; Burbes E; Coper H
    Drug Alcohol Depend; 1982; 10(2-3):191-8. PubMed ID: 6131801
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine receptors in the denervated striatum: further supersensitivity by chronic haloperidol treatment.
    Reches A; Wagner RH; Jackson V; Yablonskaya-Alter E; Fahn S
    Brain Res; 1983 Sep; 275(1):183-5. PubMed ID: 6414646
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential effects of apomorphine on spinal reflex activity following 6-hydroxydopamine or long-term haloperidol pretreatment.
    Jensen TS; Christensen NJ; Smith DF
    J Neural Transm; 1986; 65(2):125-34. PubMed ID: 3084706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine.
    Duncan GE; Criswell HE; McCown TJ; Paul IA; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1027-34. PubMed ID: 3121842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lateralized decrease in self-stimulation induced by haloperidol in rats with unilateral 6-hydroxydopamine lesions.
    Carey RJ
    Behav Brain Res; 1985 Dec; 18(3):215-22. PubMed ID: 3937541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High- and low-affinity states of striatal D2 receptors are not affected by 6-hydroxydopamine or chronic haloperidol treatment.
    MacKenzie RG; Zigmond MJ
    J Neurochem; 1984 Nov; 43(5):1310-8. PubMed ID: 6208330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypophysectomy does not alter the increase in striatal dopamine receptor density produced by 6-hydroxydopamine lesions in male rats.
    Hruska RE
    Neurosci Lett; 1986 Jul; 68(2):207-10. PubMed ID: 3092152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of renal catecholamines in the control of sodium and water excretion: lack of natriuresis by endogenous dopamine in the rat kidney.
    Sato T; Minami S; Okabe T; Igarashi N
    Acta Endocrinol (Copenh); 1987 Nov; 116(3):326-32. PubMed ID: 2825456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing pharmacologically induced dopamine receptor sensitivity changes with the Ungerstedt turning model.
    Siever L; Cohen R; Pert A
    Psychopharmacology (Berl); 1981; 75(2):212-3. PubMed ID: 6119727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of haloperidol administration on in vivo extracellular dopamine in striatum and prefrontal cortex after partial dopamine lesions.
    Bean AJ; Roth RH
    Brain Res; 1991 May; 549(1):155-8. PubMed ID: 1909923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progabide reverses the nigral substance P reduction induced by chronic impairment of dopaminergic transmission.
    Zivkovic B; Oblin A; Bartholini G
    Eur J Pharmacol; 1985 Jun; 112(2):253-5. PubMed ID: 2411575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation.
    Korf J; Sebens JB
    J Neurochem; 1987 Feb; 48(2):516-21. PubMed ID: 2878979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in striatal dopamine D2 receptor mRNA after lesions of haloperidol treatment.
    Coirini H; Schumacher M; Angulo JA; McEwen BS
    Eur J Pharmacol; 1990 Sep; 186(2-3):369-71. PubMed ID: 2127022
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term effects of nigro-striatal denervation of striatal [3H]haloperidol binding.
    Feuerstein C; Demenge P; Barrette G; Silice C; Guerin B; Mouchet P
    Eur J Pharmacol; 1981 Dec; 76(4):457-60. PubMed ID: 6799306
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of neurotensin-dopamine receptor interactions in striatal membranes of the male rat. The influence of 6-hydroxydopamine-induced dopamine receptor supersensitivity.
    Fuxe K; Agnati LF; Martire M; Neumeyer A; Benfenati F; Frey P
    Acta Physiol Scand; 1986 Jan; 126(1):147-9. PubMed ID: 3006432
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in dopamine receptors: effect of lesion and haloperidol treatment.
    Goldstein M; Lew JY; Asano T; Ueta K
    Commun Psychopharmacol; 1980; 4(1):21-5. PubMed ID: 6105037
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C; Fibiger HC; Phillips AG
    Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of supersensitivity of pre- and postsynaptic dopamine receptors on the activity of endogenous inhibitor of cAMP dependent protein kinase in rat striatum.
    Szmigielski A; Szadowska A; Szmigielska H
    Arch Int Pharmacodyn Ther; 1984 Dec; 272(2):214-24. PubMed ID: 6098230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D1 receptor behavioral responsitivity following selective lesions of the striatal patch compartment during development.
    Neal BS; Joyce JN
    Brain Res Dev Brain Res; 1991 Jun; 60(2):105-13. PubMed ID: 1832593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.